Large-scale testing (Phase 3)Study completedNCT00034879What this trial is testingIressa Expanded Access Program (EAP)Who this might be right forCarcinomaNon-small-cell LungMetastases+1 more AstraZeneca
Testing effectiveness (Phase 2)Ended earlyNCT05662670What this trial is testingA Phase I/II Study of WJ13404 Monotherapy in Patients With Advanced or Mentastatic Non-Small Cell Lung CancerWho this might be right forLocally Advanced or Metastatic NSCLC Suzhou Junjing BioSciences Co., Ltd. 14
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07609251What this trial is testingA Clinical Study of SCTB41 Combined With Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer（Phase II Study Ongoing）Who this might be right forNSCLC (Advanced Non-small Cell Lung Cancer) Sinocelltech Ltd. 90
Not applicableLooking for participantsNCT06467383What this trial is testingDescribe the Diagnostic and Therapeutic Path of Patients with NSCLC in Early Stage and Locally AdvancedWho this might be right forNon-small Cell Lung CancerNSCLCNSCLC, Stage III+1 more MSD Italia S.r.l. 600
Large-scale testing (Phase 3)Ended earlyNCT00662597What this trial is testingASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer Novartis Pharmaceuticals 1,285
Large-scale testing (Phase 3)Active Not RecruitingNCT05221840What this trial is testingA Global Study to Assess the Effects of Durvalumab With Oleclumab or Durvalumab With Monalizumab Following Concurrent Chemoradiation in Patients With Stage III Unresectable Non-Small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer AstraZeneca 1,051
Testing effectiveness (Phase 2)UnknownNCT02981108What this trial is testingEvaluate Safety, PK and Efficacy of HS-10296 in Patients With NSCLCWho this might be right forNonsmall Cell Lung Cancer Jiangsu Hansoh Pharmaceutical Co., Ltd. 364
Testing effectiveness (Phase 2)UnknownNCT04085250What this trial is testingStudy of Nivolumab for Non-Small Cell Lung Cancer (Stage III) Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiation TherapyWho this might be right forStage III Non-small-cell Lung Cancer Sun Yat-sen University 264
Not applicableUnknownNCT03741647What this trial is testingSleep Apnea and Lung CancerWho this might be right forLocally Advanced Non Small Cell Lung Cancer Zagazig University 50
Testing effectiveness (Phase 2)Ended earlyNCT04585815What this trial is testingStudy of Immunotherapy (Sasanlimab) in Combination With Targeted Therapies in People With Advanced Non-small Cell Lung Cancer (NSCLC) (Landscape 1011 Study)Who this might be right forCarcinoma, Non-Small-Cell Lung Pfizer 34
Not applicableLooking for participantsNCT03742687What this trial is testingHeterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLCWho this might be right forStage III Non-small-cell Lung CancerStage IV Non-small Cell Lung CancerRadiotherapy Side Effect Danish Lung Cancer Group 151
Early research (Phase 1)Study completedNCT01167530What this trial is testingStudy to Evaluate RAD001 in Combination With Radiotherapy in Non-small Cell Lung CancerWho this might be right forNon-small Cell Lung CancerLocally Advanced Disease Gustave Roussy, Cancer Campus, Grand Paris 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT07005336What this trial is testingCompare Uliledlimab Combined With Sintilimab and Chemotherapy Versus Sintilimab Combined With Chemotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic Non-small Cell Lung CancerWho this might be right forNon Small Cell Lung Cancer TJ Biopharma Co., Ltd. 150
Very early researchStudy completedNCT05873439What this trial is testingGenomically Guided Radiation Dose Personalization in Locally Advanced NSCLCWho this might be right forNonsmall Cell Lung CancerNonsmall Cell Lung Cancer, Stage IINonsmall Cell Lung Cancer Stage III+1 more H. Lee Moffitt Cancer Center and Research Institute 3
Early research (Phase 1)Active Not RecruitingNCT02321501What this trial is testingCeritinib and Everolimus in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIB-IV Non-small Cell Lung CancerWho this might be right forALK PositiveLocally Advanced Malignant Solid NeoplasmMetastatic Malignant Solid Neoplasm+3 more M.D. Anderson Cancer Center 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT05801029What this trial is testingInvestigate Safety and Efficacy of Osimertinib and Amivantamab in Participants With Non-small Cell Lung Cancer With Common Epidermal Growth Factor Receptor MutationsWho this might be right forNon-Small Cell Lung Cancer (NSCLC) AstraZeneca 60
Testing effectiveness (Phase 2)Looking for participantsNCT06388031What this trial is testingICI Rechallenge for Advanced NSCLC With Long-Term Response to First-Line ICIWho this might be right forNon-small Cell Lung Cancer Peking Union Medical College Hospital 27
Large-scale testing (Phase 3)Active Not RecruitingNCT05009836What this trial is testingClinical Study on Savolitinib + Osimertinib in Treatment of EGFRm+/MET+ Locally Advanced or Metastatic NSCLCWho this might be right forNon-small Cell Lung Cancer Hutchmed 412
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06185400What this trial is testingRC48 Combined With EGFR or HER2 TKI for Locally Advanced or Metastatic NSCLC Patients With HER2 AlterationsWho this might be right forNon Small Cell Lung CancerERBB2 Mutation-Related TumorsERBB2 Gene Duplication+1 more Cancer Institute and Hospital, Chinese Academy of Medical Sciences 108
Testing effectiveness (Phase 2)Active Not RecruitingNCT04579380What this trial is testingBasket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 AlterationsWho this might be right forUterine NeoplasmsUterine Cervical NeoplasmsBiliary Tract Neoplasms+3 more Seagen, a wholly owned subsidiary of Pfizer 217